 |
Guanethidine monosulfate |
|---|---|
| Trade Name | Ismelin |
| Orphan Indication | Moderate to severe reflex sympathetic dystrophy and causalgia |
| USA Market Approval | USA |
| USA Designation Date | 1986-01-06 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936 |
